Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis
Abstract Background Multi drug-resistant and mycobacterial infections are a major public health challenge, leading to high mortality and socioeconomic burdens through worldwide. Novel therapeutics are necessary to treat the drug resistant strains, since no new chemical entities are emerged in the la...
Main Authors: | Mohana Rao Anguru, Ashok Kumar Taduri, Rama Devi Bhoomireddy, Malathi Jojula, Shravan Kumar Gunda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Chemistry Central Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13065-017-0295-z |
Similar Items
-
Antibacterial Components of Levisticum officinale Koch against Multidrug-resistant Mycobacterium tuberculosis
by: Hamidreza Monsef Esfahani, et al.
Published: (2020-12-01) -
Synthesis and Antimycobacterial Activity of 2,5-Disubstituted and 1,2,5-Trisubstituted Benzimidazoles
by: Rogelio Jiménez-Juárez, et al.
Published: (2020-06-01) -
ANTIBACTERIAL ACTIVITY OF BENZIMIDAZOLES 2-THIO, 2-AMINODERIVATIVES AND COMPLEXES OF BENZIMIDAZOLES WITH TRANSITIONAL METALS
by: E. I. Mayboroda, et al.
Published: (2015-09-01) -
Virtual screening studies to identify novel inhibitors for Sigma F protein of Mycobacterium tuberculosis
by: Kiran Kumar Mustyala, et al.
Published: (2015-01-01) -
Arabinosyl transferase inhibitor design against Mycobacterium tuberculosis using ligand based drug design approach
by: Bhaskor Kolita, et al.
Published: (2014-05-01)